• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Med (Lausanne) . Use of trained scent dogs for detection of COVID-19 and evidence of cost-saving

tetano

Editor, Senior Moderator
Front Med (Lausanne)


. 2022 Dec 1;9:1006315.
doi: 10.3389/fmed.2022.1006315. eCollection 2022.
Use of trained scent dogs for detection of COVID-19 and evidence of cost-saving


Leon Mutesa[SUP] 1 2 [/SUP], Gashegu Misbah[SUP] 2 [/SUP], Eric Remera[SUP] 2 [/SUP], Hans Ebbers[SUP] 3 [/SUP], Esther Schalke[SUP] 3 [/SUP], Patrick Tuyisenge[SUP] 2 [/SUP], Reuben Sindayiheba[SUP] 2 [/SUP], Clement Igiraneza[SUP] 2 [/SUP], Jeanine Uwimana[SUP] 2 [/SUP], Diane Mbabazi[SUP] 2 [/SUP], Epimaque Kayonga[SUP] 4 [/SUP], Michel Twagiramungu[SUP] 4 [/SUP], Denyse Mugwaneza[SUP] 2 [/SUP], Leandre Ishema[SUP] 2 [/SUP], Yvan Butera[SUP] 1 2 [/SUP], Clarisse Musanabaganwa[SUP] 1 2 [/SUP], Edson Rwagasore[SUP] 2 [/SUP], Friederike Twele[SUP] 5 [/SUP], Sebastian Meller[SUP] 5 [/SUP], Albert Tuyishime[SUP] 2 [/SUP], Robert Rutayisire[SUP] 2 [/SUP], Marilyn Milumbu Murindahabi[SUP] 2 [/SUP], Lindsay A Wilson[SUP] 6 [/SUP], Noella Bigirimana[SUP] 2 [/SUP], Holger A Volk[SUP] 5 [/SUP], Vedaste Ndahindwa[SUP] 2 [/SUP], Benoit Kayijuka[SUP] 4 [/SUP], Edward J Mills[SUP] 7 [/SUP], Claude Mambo Muvunyi[SUP] 2 [/SUP], Sabin Nsanzimana[SUP] 2 [/SUP]



Affiliations

Abstract

Background: One of the lessons learned from the coronavirus disease 2019 (COVID-19) pandemic is the importance of early, flexible, and rapidly deployable disease detection methods. Currently, diagnosis of COVID-19 requires the collection of oro/nasopharyngal swabs, nasal turbinate, anterior nares and saliva but as the pandemic continues, disease detection methods that can identify infected individuals earlier and more quickly will be crucial for slowing the spread of the virus. Previous studies have indicated that dogs can be trained to identify volatile organic compounds (VOCs) produced during respiratory infections. We sought to determine whether this approach could be applied for detection of COVID-19 in Rwanda and measured its cost-saving.
Methods: Over a period of 5 months, four dogs were trained to detect VOCs in sweat samples collected from human subjects confirmed positive or negative for COVID-19 by reverse transcription polymerase chain reaction (RT-PCR) testing. Dogs were trained using a detection dog training system (DDTS) and in vivo diagnosis. Samples were collected from 5,253 participants using a cotton pad swiped in the underarm to collect sweat samples. Statistical analysis was conducted using R statistical software.
Findings: From August to September 2021 during the Delta wave, the sensitivity of the dogs' COVID-19 detection ranged from 75.0 to 89.9% for the lowest- and highest-performing dogs, respectively. Specificity ranged from 96.1 to 98.4%, respectively. In the second phase coinciding with the Omicron wave (January-March 2022), the sensitivity decreased substantially from 36.6 to 41.5%, while specificity remained above 95% for all four dogs. The sensitivity and specificity by any positive sample detected by at least one dog was 83.9, 95% CI: 75.8-90.2 and 94.9%; 95% CI: 93.9-95.8, respectively. The use of scent detection dogs was also found to be cost-saving compared to antigen rapid diagnostic tests, based on a marginal cost of approximately $14,000 USD for testing of the 5,253 samples which makes 2.67 USD per sample. Testing turnaround time was also faster with the scent detection dogs, at 3 h compared to 11 h with routine diagnostic testing.
Conclusion: The findings from this study indicate that trained dogs can accurately identify respiratory secretion samples from asymptomatic and symptomatic COVID-19 patients timely and cost-effectively. Our findings recommend further uptake of this approach for COVID-19 detection.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; cost-saving; scent dogs; volatile organic compounds (VOCs).
 
Back
Top Bottom